Sprix FDA Approval History
Sprix (ketorolac tromethamine) is an intranasal analgesic for the management of acute moderate to severe pain.
Development Timeline for Sprix
|May 17, 2010||Roxro Announces FDA Approval of Sprix|
|Feb 6, 2009||Roxro Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.